Ouyang, Q., Rodon, J., Liang, Y., Wu, X., Li, Q., Song, L., . . . Yin, Y. Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies. BMC.
Chicago Style (17th ed.) CitationOuyang, Quchang, et al. Results of a Phase 1/2 Study of Sacituzumab Tirumotecan in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies. BMC.
MLA (9th ed.) CitationOuyang, Quchang, et al. Results of a Phase 1/2 Study of Sacituzumab Tirumotecan in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies. BMC.
Warning: These citations may not always be 100% accurate.